Accupril: Effective Blood Pressure Control for Cardiovascular Health
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.13 | $68.06 (0%) | 🛒 Add to cart |
| 90 | $0.92 | $102.09 $83.07 (19%) | 🛒 Add to cart |
| 120 | $0.85 | $136.12 $102.09 (25%) | 🛒 Add to cart |
| 180 | $0.80 | $204.18 $144.13 (29%) | 🛒 Add to cart |
| 270 | $0.75 | $306.28 $203.18 (34%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $408.37 $256.23 (37%) | 🛒 Add to cart |
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor prescription medication clinically proven to manage hypertension and heart failure. This pharmaceutical agent works by relaxing blood vessels, allowing blood to flow more smoothly and reducing the heart’s workload. Through its targeted mechanism of action, Accupril helps patients achieve sustained blood pressure control, potentially reducing long-term cardiovascular risks. Medical professionals frequently prescribe this medication as part of comprehensive treatment plans for patients requiring reliable antihypertensive therapy.
Features
- Contains quinapril hydrochloride as the active pharmaceutical ingredient
- Available in multiple tablet strengths (5 mg, 10 mg, 20 mg, 40 mg)
- Once or twice-daily dosing regimen for patient convenience
- FDA-approved for hypertension and heart failure management
- Demonstrated efficacy in clinical trials involving diverse patient populations
- Manufactured under strict quality control standards
Benefits
- Effectively lowers high blood pressure, reducing strain on the cardiovascular system
- May improve survival rates in patients with congestive heart failure when used as part of comprehensive therapy
- Helps protect kidney function in hypertensive patients with diabetes
- Can be used as monotherapy or in combination with other antihypertensive agents
- Provides 24-hour blood pressure control with appropriate dosing
- May reduce the risk of heart attack, stroke, and other cardiovascular events in high-risk patients
Common use
Accupril is primarily prescribed for the management of hypertension (high blood pressure) in adults. It is also indicated for the treatment of heart failure as adjunctive therapy when added to conventional treatments including diuretics and digitalis. Additionally, Accupril may be used following heart attack in clinically stable patients with left ventricular dysfunction to improve survival. Some physicians may prescribe Accupril off-label for certain kidney conditions related to diabetes, though this use should be carefully monitored by healthcare professionals.
Dosage and direction
The dosage of Accupril must be individualized based on the patient’s medical condition and response to treatment. For hypertension, the initial dose is typically 10-20 mg once daily. For patients on diuretic therapy, the recommended starting dose is 5 mg once daily. The maintenance dose ranges from 20-80 mg daily, administered as a single dose or divided into two doses. For heart failure, therapy is usually initiated at 5 mg twice daily, which may be increased weekly until the effective tolerated dose is reached (typically 20-40 mg daily in two divided doses). Tablets should be swallowed whole with water, with or without food, though consistency in administration relative to meals is recommended. Dosage adjustments are necessary for patients with renal impairment.
Precautions
Before taking Accupril, patients should inform their healthcare provider about any history of kidney disease, liver disease, diabetes, collagen vascular disease, or if they are on a salt-restricted diet. Patients should maintain adequate fluid intake to prevent dehydration and hypotension. Regular blood pressure monitoring and kidney function tests are recommended during treatment. Accupril may cause dizziness, especially during the first few days of therapy or after dosage increases; patients should avoid driving or operating machinery until they know how the medication affects them. This medication may increase potassium levels; potassium supplements or salt substitutes containing potassium should not be used unless directed by a physician. Angioedema (swelling of face, lips, tongue, or throat) has been reported with ACE inhibitors and requires immediate medical attention.
Contraindications
Accupril is contraindicated in patients with a history of angioedema related to previous ACE inhibitor treatment. It should not be used in patients with hereditary or idiopathic angioedema. The medication is contraindicated in combination with aliskiren in patients with diabetes. Accupril is also contraindicated during the second and third trimesters of pregnancy due to potential fetal harm. Patients with bilateral renal artery stenosis or stenosis of the artery to a single kidney should not take this medication. Hypersensitivity to quinapril or any other ACE inhibitor constitutes another contraindication.
Possible side effect
Common side effects may include dizziness (8-19%), headache (3-6%), cough (2-4%), fatigue (2-3%), and nausea (1-2%). Less frequently, patients may experience orthostatic hypotension, hyperkalemia, rash, impotence, diarrhea, or vomiting. Serious side effects requiring immediate medical attention include angioedema (swelling of face, lips, tongue, or throat), jaundice, signs of infection (fever, sore throat), chest pain, irregular heartbeat, or symptoms of high potassium levels (muscle weakness, slow heart rate). Renal impairment may occur, particularly in patients with congestive heart failure, renal artery stenosis, or volume depletion.
Drug interaction
Accupril may interact with several medications including diuretics (increased risk of hypotension), lithium (increased lithium levels), nonsteroidal anti-inflammatory drugs (may reduce antihypertensive effect), potassium-sparing diuretics or potassium supplements (increased risk of hyperkalemia), and gold injections (nitritoid reactions). Concurrent use with angiotensin receptor blockers or aliskiren may increase the risk of hypotension, hyperkalemia, and renal impairment. Diabetic patients taking insulin or oral hypoglycemic agents may experience enhanced blood glucose-lowering effects. Tetracycline absorption may be reduced when taken concurrently with Accupril.
Missed dose
If a dose of Accupril is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one. Consistency in taking Accupril is important for maintaining stable blood pressure control. If multiple doses are missed, patients should contact their healthcare provider for guidance, as blood pressure may increase when medication is not taken regularly.
Overdose
Accupril overdose may manifest as severe hypotension, which can lead to circulatory shock. Other symptoms may include bradycardia, electrolyte disturbances, and renal failure. In case of suspected overdose, immediate medical attention is required. Treatment is primarily supportive and symptomatic, including volume expansion with normal saline to restore blood pressure. Hemodialysis may be effective in removing quinapril and its metabolites from the circulation. Patients should be monitored for hypotension for at least 24 hours, with particular attention to renal function and electrolyte balance.
Storage
Accupril tablets should be stored at room temperature (15-30°C or 59-86°F) in their original container, protected from light and moisture. The medication should be kept out of reach of children and pets. Tablets should not be stored in bathrooms or other areas with high humidity. Unused medication should be properly discarded after the expiration date printed on the packaging. Patients should not flush medications down the toilet or pour them into drains unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Accupril is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients should not initiate, discontinue, or change their dosage of Accupril without consulting their physician. Individual responses to medication may vary, and only a healthcare provider can determine the appropriate treatment based on a patient’s specific medical condition, other medications, and overall health status.
Reviews
Clinical studies have demonstrated Accupril’s efficacy in blood pressure control, with many patients achieving target blood pressure goals. In the QUinapril Ischemic Event Trial (QUIET), Accupril showed beneficial effects on endothelial function in patients with coronary artery disease. Patient reviews often note effective blood pressure management, though some report the characteristic ACE inhibitor cough as a limiting factor. Many healthcare professionals appreciate Accupril’s generally favorable side effect profile compared to some other antihypertensive agents and its once-daily dosing convenience for improved adherence. Long-term users frequently report stable blood pressure control with minimal side effects when properly dosed.